In the kidney, neutral endopeptidase (NEP) is implicated in the metabolism of several peptides involved in blood pressure and sodium homeostasis control, such as the atrial natriuretic peptide, bradykinin and angiotensin I. Due to its physiological importance in the modulation of pressor responses, the presence of NEP in mouse mesangial cells has been investigated, since these cells control glomerular function and are able to synthesise components of the renin-angiotensin system. A NEP-like activity (NEP-like) that cleaves the fluorogenic substrates Abz-BKQ-EDDnp and Abz-DRRL-EDDnp was purified from mesangial cell lysate by ion-exchange, followed by gel filtration chromatography. The enzyme was able to hydrolyse bradykinin at the G 4 -F 5 peptide bond and was inhibited by thiorphan. A pH study established that enzyme activity was maximal at pH 7.5 and the determined K m was 4.86 µM using Abz-DRRL-EDDnp as substrate. NEP-like was recognised by monoclonal anti-NEP and had a molecular mass of 95 kDa. The purified enzyme was sequenced and showed similarity with human, rat, mouse and rabbit NEPs. We isolated, for the first time, NEP-like from mesangial cells. This enzyme could have an important role in the renal physiology by its action upon different peptides that are able to alter renal haemodynamics.
Introduction
Neutral endopeptidase (NEP, neprilysin, EC 3.4.24.11) is a 94-kDa zinc metalloendopeptidase located on the cell surface which functions as an ectoenzyme, catalysing peptide hydrolysis at the extracellular face of the plasma membrane. 1 The enzyme was first isolated from the brush-border membranes of the kidney 2, 3 and was subsequently found in a wide range of tissues, including the central nervous system. [4] [5] [6] NEP is present in human urine 7, 8 and is one of the major kininases found in rat urine. 9 The first relevant physiological substrates revealed for NEP were the enkephalins and substance P, 4, 5 focusing on its role in turning off neuropeptide signals in the brain. A variety of other physiological substrates has subsequently been revealed for NEP, including the vasodilator atrial natriuretic peptide (ANP), [10] [11] [12] and bradykinin (BK: R 1 -P 2 -P 3 -G 4 -F 5 -S 6 -P 7 -F 8 -R 9 ), which is inactivated by hydrolysis of the G 4 -F 5 and P 7 -F 8 peptide bonds. 6 Several synthetic substrates have been developed to measure NEP activity, such as radiolabelled, chromogenic and fluorogenic peptides. Medeiros et al. 13 described a new intramoleculary-quenched fluorogenic substrate for NEP, Abz-DRRL-EDDnp, which is totally resistant to the action of other metalloproteases, serineproteases and proteases present in homogenates of several tissues, suggesting its use for specific NEP assays in enzyme preparations.
The renin-angiotensin system (RAS) is considered one of the most important regulatory systems of cardiovascular homeostasis. Recently, inhibition of NEP, as well as inhibition of angiotensin-converting enzyme (ACE), have gained increasing interest in the treatment of hypertension [14] [15] [16] and heart failure. [17] [18] [19] The alternative formation of angiotensin-(1-7) [Ang-(1-7)] from angiotensin I (Ang I), catalysed primarily by NEP 20 (Figure 1 ), has been studied as a mechanism to offset the pressor and proliferative actions of angiotensin II (Ang II). [21] [22] [23] [24] Mesangial cells (MC) are both a target 25 and a degradation site for Ang II. The latter function is caused by the presence of a variety of peptidases on the cell surface that are able to catabolise this hormone. Besides angiotensin receptors, BK receptors were identified on MC, 26 and these cells were described as producing ACE. 27 Enzymes that are able to release and/or inactivate hormones are important in MC physiology, as well as in the glomerulus, which also contains high levels of ANP and BK receptors. This study was performed to investigate NEP expression and activity in MC in culture.The presence of NEP in these cells might thus account for the pharmacological effects of NEP inhibitors in diuresis and natriuresis in the whole kidney and also could establish this cell line as a potentially useful model for the study of targetting mechanisms.
Material and methods
This study was approved by the Ethics Committee of the Federal University of São Paulo, São Paulo, Brazil.
Immortalised mesangial cell culture (IMC)
Cells were purchased from the American Type Culture Collection (ATCC: CRL-1927). Mouse IMC were plated onto DMEM (Gibco BRL), supplemented with 5% foetal bovine serum (FBS), 5,000 U/L penicillin, and 50 mg/L streptomycin. Before the experiments, IMC were incubated with DMEM without FBS for 24 hours.The culture flasks were rinsed twice with phosphate-buffered saline (PBS), scraped in 2 ml of PBS and centrifuged at 3,000 rpm for 10 minutes. The supernatant was poured out and the cell pellet was stored at -80°C.
Purification of NEP-like enzyme
The mesangial cell pellet was resuspended in 20 mM sodium phosphate buffer, pH 7.0 (buffer A). After a sonication procedure, the cellular lysate was centrifuged (3,000 rpm) for 10 minutes at 4°C. The supernatant was submitted to ionexchange chromatography on a Mono-Q column (1 ml) (Amersham Pharmacia Biosciences) equilibrated with buffer A in a fast performance liquid chromatography system (FPLC) (Amersham Pharmacia Biosciences). Elution at 30 ml/hour was carried out at pH 7.0 with a stepwise increase in ionic strength of sodium phosphate buffer (20, 200, 250 , 300 and 500 mM). Pooled fractions eluted from the Mono-Q column were submitted to gel filtration on a Superdex-200 column (Amersham Pharmacia Biosciences) in the same system described above, equilibrated with 50 mM Tris-HCl buffer, pH 7.0, containing 150 mM NaCl and eluted with the same buffer at a flow rate of 60 ml/hour.
Protein determination
Protein concentration was determined by the Bradford method, 28 using bovine albumin as standard (Bio-Rad Protein Assay kit, Bio-Rad Laboratories).Absorbance at 280 nm was used for the chromatographic elution profile.
Enzymatic activity assay NEP-like enzymatic activity was assayed through its ability to hydrolyse the intramolecularyquenched fluorogenic substrates,Abz-BKQ-EDDnp and Abz-DRRL-EDDnp. 12 Fluorescence was measured continuously for 10 minutes in the cuvette of the spectrofluorimeter (Hitachi) at λ em = 420 nm and λ ex = 320 nm. NEP activity was determined with 5 µM substrate, in 50 mM sodium phosphate buffer, pH 7.0, at 37°C.The proteolytic activity was expressed as the release rate of fluorescent fragments in nM/min/ml.
Inhibition studies
The enzyme solution was preincubated with thiorphan, 5 µM in 50 mM sodium phosphate buffer, pH 7.0, in a final volume of 100 µl, for 30 minutes at 37°C before determination of activity, as described above.The results were recorded as the percentage of residual activity relative to control reactions run simultaneously in the absence of the inhibitor.
pH profile of the NEP-like enzyme activity NEP-like activity at various pH values was measured at 37°C by the fluorimetric assay described above, using Abz-DRRL-EDDnp as substrate.The following buffers were used: 50 mM sodium acetate (pH 5.0 and 5.5), 50 mM sodium phosphate (pH 6.0, 6.5 and 7.0), 50 mM Tris-HCl (pH 7.5, 8.0 and 8.5) and 50 mM glycine-NaOH (pH 9.0 and 10.0).
Kinetic parameters
The Michaelis-Menten (K m ) constant, using the fluorogenic substrate Abz-DRRL-EDDnp, was determined for NEP-like enzyme at 37°C, pH 7.5 in 50 mM Tris-HCl buffer, following the protocol described above. Different substrate concentrations were used, ranging from 0.134 to 16.75 µM. K m value was determined by Lineweaver-Burk equation and the data analysed using the computer programme Grafit 4.0 (Erithacus Software Ltd).
Dot blot and immunoblot analysis
An aliquot (50 µl) of the fractions collected from the chromatography procedure was filtered through a nitrocellulose membrane (Amersham Pharmacia Biosciences) by gravity flow for 30 minutes in the dot-blot system. The Bio-Dot Microfiltration Apparatus and all subsequent steps were prepared as recommended by the manufacturer (Bio-Rad Laboratories).
Proteins were analysed by sodium dodecyl sulfate-polyacrylamide gel (7.5%) electrophoresis (SDS-PAGE), performed by the Laemmli 29 method under reducing conditions. Electrotransference was performed using a nitrocellulose membrane. Membranes were incubated with blocking solution for 6 hours before 8 hours incubation with mouse anti-NEP monoclonal antibody (1:1000 dilution). The antibody was obtained from purified recombinant NEP, a generous gift from Prof. Dr Guy Boileau, Université Montreal, Canada. Subsequent steps were performed with the streptavidin/phosphatase alkaline system (Amersham Pharmacia Biosciences) and protein bands were finally developed using BCIP/NBT as substrates, as recommended by the manufacturer (Bio-Rad Laboratories). Image analysis was performed using GS-710 Callibrated Imaging Densitometer (Bio-Rad Laboratories).
Identification of BK hydrolysis products
The products derived from BK after hydrolysis by NEP-like from IMC were separated by HPLC with Aliquots were taken at 0 minutes and after 6 hours of incubation. For chromatographic identification of the hydrolysis products, 100 µl of the incubation mixture was analysed by reverse-phase HPLC, using an Aquapore OD-300 7 µ column (250x4.6mm) (Brownlee Labs) equilibrated with 0.1% phosphoric acid containing 5% acetonitrile (v/v). Peptides were separated by isocratic elution for 5 minutes, followed by a 20-minute linear gradient of 5-35% (v/v) acetonitrile in 0.1% phosphoric acid at 1.5 ml/minute. Reaction products were detected by absorbance at 214 nm.
NEP-like sequence
After SDS-PAGE, proteins were electroblotted to a PVDF protein sequencing membrane (Bio-Rad Laboratories), using 100 mM Caps, pH 11.0, in transfer buffer. Staining with 2% Ponceau S in 1% acetic acid was performed to localise the protein band on the membrane. NEP protein bands (two bands, each approx. 50 µg) were excised from the blot and subjected to N-terminal sequence analysis, using the Protein Sequencer PPSQ-23 System (Shimadzu Corporation).
Results

Purification of NEP-like
Ion-exchange chromatography of the proteins from the IMC homogenate produced one protein peak with NEP-like activity, that was eluted with 500 mM sodium phosphate buffer, as shown in Figure 2 . The majority of the Abz-DRRL-EDDnp hydrolysis was present between tubes 62-67.
Using dot-blot analysis, the same fractions reacted with anti-NEP monoclonal antibody, showing a relative density profile similar to NEP-like activity (Figure 3 ).The pooled fractions were submitted to gel filtration chromatography. The enzyme was purified 2.96 fold with a specific activity of 6,087 nM/mg cell protein ( Table 1) .
Characterisation of NEP-like
NEP-like proteolytic activity (NEP-like) was found to exhibit a broad optimum pH ranging from 7.0 to 8.0, using Abz-DRRL-EDDnp as substrate; therefore, all assays were routinely performed at these pHs. The K m value found for this substrate was PAPER (Figure 4) . The purified NEP-like was resolved by SDS-PAGE and revealed by immunoblotting using anti-NEP antibody ( Figure 5 ), and the molecular mass determined was 95 kDa. The partial N-terminal sequence of purified NEP-like is shown in Table 2 .
Discussion
The great interest in members of the neprilysin family as putative therapeutic targets and the previous studies of our group identifying NEP in human 7, 8 and more recently in rat urine, 30 led us to investigate whether additional members of the family remained to be identified.
In this study, we purified, for the first time, NEP from MC. Data from the literature 31 and personal results obtained by cell fractionation with systematic centrifugation, followed by immunoblotting, led us to verify that NEP-like was associated with the membrane fraction in mesangial cells (data not shown). However, this procedure results in low protein recuperation and decreased enzyme activity due to extensive manipulation. Thus, in the purification procedure, the cells are sonicated to avoid disruption, and also to liberate the proteins once anchored to the membrane. The purified enzyme could effectively act as an endopeptidase with a catalytic mechanism similar to NEP purified from rat brain 32 and human urine, 7,8 since it was able to hydrolyse the G 4 -P 5 peptide bond of BK. The use of biologically-active peptide BK as a substrate provides a sensitive method which serves to complement other substrates used for the assay of peptidase activity.A major problem in the study of intracellular proteinases and peptidases has been in the selection of the substrate used to detect enzyme activity in cell lysate and to monitor the steps in a purification procedure.The fluorogenic substrate,Abz-DRRL-EDDnp, specific for NEP, 13 was also an excellent substrate for NEP-like, with a high specificity. The K m value found for this substrate was 4.86 µM, similar to that obtained by Medeiros et al. 13 Furthermore, a well-known NEP inhibitor, thiorphan, 33 also decreased NEP-like activity. From the experiments carried out, the optimum environment for the enzyme was found to be pH 7.5, a value similar to that shown for NEP activity in different tissues. 3 Despite the fact that we are using a fluorogenic substrate with a high degree of specificity for NEP, we observed that the enzyme activity readily decreased during the chromatographic steps and was extremely unstable even with control of room temperature and sample storage at 4°C. In this work, to improve the method of NEP purification, we performed a one-day purification procedure, to try to preserve NEP-like activity as much as possible; nevertheless, we didn't achieve the expected success. Although we had a low degree of purification (2.96-fold), the enzyme was purified until homogeneity which could be observed by Ponceau stain and confirmed by immunoblotting.
The 95 kDa molecular mass found for NEP-like is similar to that reported for NEP from human kidney (90 kDa), 38 rabbit kidney (94 kDa) 39, 40 and from human urine (94 kda). 7 Differences in the size of NEP from various tissues have been observed previously and attributed to differences in glycosylation. 41 Analysis of the amino acid sequence revealed that this NEP-like shows similarity with human, rabbit, rat and mouse NEP, 39, [42] [43] [44] another strong indication that the investigated enzyme is NEP, confirming the reaction of the enzyme with anti-NEP antibody.
Our findings support the fact that soluble NEPlike in urine was synthesised by the kidney itself, since its 94 kDa molecular mass prevents it from being filtered by the glomerulus. NEP exhibits a wide tissue distribution, but the highest neprilysin concentration was found to be in the kidney, where the enzyme is located primarily on the proximal tubule brush border membranes. 2,3 Using a micropuncture technique, Casarini et al. 45 described the presence of neprilysin in tubular fluid along the rat nephron. Immunochemical studies in the kidney 46, 47 have led to contradictory data about the presence of NEP in the glomeruli when investigated in different species. However, direct measurement in glomerular preparations revealed NEP activity in the dog, rat and rabbit kidney. [48] [49] [50] The description of NEP activity in MC by Albrightson 51 and the purification and characterisation of NEP-like in this study, clearly demonstrate that MCs contain this enzyme, and that it could be responsible for Ang-(1-7) production, since this peptide was detected in the same cells by immunofluorescence analysis in our laboratory (data not shown). The presence of active NEP in glomeruli is of greater physiological importance, owing to the existence of functional receptors of the natriuretic peptide in the mesangial and epithelial cells of glomeruli. In proximal tubules, it has been shown that NEP takes part in the metabolism of kinins, possibly as a helper enzyme, thus affecting the regulation of water and sodium excretion, as well as the pathophysiology of some forms of hypertension. 52, 53 The effect of NEP on cultured MC has not yet been examined, but it could be involved in the actions of the new drug class of vasopeptidase inhibitors in the treatment of hypertension. The mechanisms by which ACE inhibitors exert their effects are not entirely understood. Several studies suggest that potentiation of BK through diverse mechanisms plays a pivotal role. 54, 55 However, it has been proposed that Ang-(1-7) may also mediate some ACE inhibitor-related effects. This has led to the concept that Ang-(1-7) may be an endogenous counterplayer of the RAS through a wide variety of mechanisms. 24 Recently, NEP inhibition, as well as ACE inhibition, gained increasing interest in the treatment of hypertension [14] [15] [16] and heart failure. [17] [18] [19] Both ACE and NEP participate in the metabolism of angiotensin and BK.ACE inhibitors prevent the pressor response to Ang I, and both ACE and NEP inhibitors potentiate the depressor effects of BK. 56 Taken together, these results illustrate the importance of identifying and characterising an enzyme that may exert autocrine and paracrine effects (since it seems to be secreted) playing a role in the control of biological active peptides in the kidney.These cells in culture could be a useful tool to study alterations in the synthesis and levels of NEP in experimental physiological and pathophysiological models of renal diseases. More studies concerning NEP-like localisation in the cell and its physiological actions will be needed to understand its main role in MC and possibly help in the study for treatment of hypertension. 
